Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortiumBastian Neesgaard, Lene Ryom, Anders Sönnerborg et al.|The Lancet HIV|2022Cited by 140
Safe Interruption of Maintenance Therapy against Previous Infection with Four Common HIV-Associated Opportunistic Pathogens during Potent Antiretroviral TherapyOle Kirk, Peter Reiss, Caterina Uberti‐Foppa et al.|Annals of Internal Medicine|2002Cited by 136
Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIVNadine Jaschinski, Lene Ryom, Lauren Greenberg et al.|AIDS|2022Cited by 38
Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment–Experienced People Living With Human Immunodeficiency VirusLauren Greenberg, H Appoyer, Lene Ryom et al.|Clinical Infectious Diseases|2020Cited by 22
Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIVLauren Greenberg, Lene Ryom, Elżbieta Bąkowska et al.|Cancers|2023Cited by 19